Jannah Baker
Overview
Explore the profile of Jannah Baker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker J, Noguchi N, Marinovich M, Sprague B, Salisbury E, Houssami N
Breast
. 2024 Sep;
78:103807.
PMID: 39270543
Background: Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast...
2.
Li L, Baker J, Saavedra A, Suster C, Moscova M, Iredell J, et al.
Health Sci Rep
. 2024 Jun;
7(6):e2162.
PMID: 38899001
Background And Aims: Blood and urine are the most common culture testing for sepsis patients. This study aimed to compare clinical characteristics and outcomes of sepsis patients by blood and...
3.
Li L, Baker J, Quirk R, Deidun D, Moran M, Salem A, et al.
Drug Saf
. 2024 Mar;
47(6):557-569.
PMID: 38478349
Introduction: Drug-drug interactions (DDIs) have potential to cause patient harm, including lowering therapeutic efficacy. This study aimed to (i) determine the prevalence of potential DDIs (pDDIs); clinically relevant DDIs (cDDIs),...
4.
Winkler N, Koirala A, Kaur G, Prasad S, Hirani R, Baker J, et al.
BMJ Open
. 2024 Feb;
14(2):e075569.
PMID: 38326269
Introduction: Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes encephalitis and other morbidity in Southeast Asia. Since February 2022, geographically dispersed JEV human, animal and vector detections occurred...
5.
Shetty A, Baker J, Kabil G, Saavedra A, Suster C, Moscova M, et al.
Emerg Med Australas
. 2022 Dec;
35(2):325-332.
PMID: 36509513
Objectives: To investigate the association between the timing and adequacy of antibiotics administered to patients presenting with culture-positive sepsis and septic shock to the ED and in-hospital mortality and/or intensive...
6.
Li L, Baker J, Rathnayake K, Kotwal S, Westbrook J, Day R, et al.
Intern Med J
. 2022 Oct;
53(9):1625-1633.
PMID: 36264150
Background And Aims: Medications remain an important contributor to the development of acute kidney injury (AKI). This study aimed to examine associations between (i) administration of medications known to reduce...
7.
Ackermann K, Baker J, Festa M, McMullan B, Westbrook J, Li L
JMIR Med Inform
. 2022 May;
10(5):e35061.
PMID: 35522467
Background: Sepsis is a severe condition associated with extensive morbidity and mortality worldwide. Pediatric, neonatal, and maternal patients represent a considerable proportion of the sepsis burden. Identifying sepsis cases as...
8.
Ackermann K, Baker J, Green M, Fullick M, Varinli H, Westbrook J, et al.
J Med Internet Res
. 2022 Feb;
24(2):e31083.
PMID: 35195528
Background: Sepsis is a significant cause of morbidity and mortality worldwide. Early detection of sepsis followed promptly by treatment initiation improves patient outcomes and saves lives. Hospitals are increasingly using...
9.
Li L, Ackermann K, Baker J, Westbrook J
JMIR Res Protoc
. 2020 Nov;
9(11):e24899.
PMID: 33215998
Background: Sepsis is a leading cause of death in hospitals, with high associated costs for both patients and health care systems worldwide. Early detection followed by timely intervention is critical...
10.
Xie Y, Baker J, Young T, Jun M, Sukkar L, Campain A, et al.
Diabetes Care
. 2020 Sep;
43(11):e185-e187.
PMID: 32928956
No abstract available.